| Symbol | MEDXF |
|---|---|
| Name | MEDEXUS PHARMACEUTICALS INC |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | MSC1C3 Canada ON 10 King Street East, Suite 600 |
| Telephone | +1 480-625-5772 |
| Fax | — |
| — | |
| Website | https://www.medexus.com/ |
| Incorporation | CA |
| Incorporated On | 2013 |
| Employees | — |
| Fiscal Year | 3/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | PricewaterhouseCoopers LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Toronto Stock Exchange |
| CIK | 0001806605 |
| Description | Medexus Pharmaceuticals, Inc. is a rapidly growing, commercial-stage specialty pharmaceutical company with an established presence across North America that is focused on therapeutic areas rheumatology, auto-immune disease, specialty oncology, allergy, and pediatric diseases. Additional info from OTC: |
OTCQX International symbol attribute type Security_Name was changed. Previous value: -. New value: MEDEXUS PHARMS INC.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: MEDEXUS PHARMS INC.
Read more